What cholecalciferol dosing regimen should be used to correct a 25‑hydroxyvitamin D level of 8 ng/mL in an adult?

Cholecalciferol Dosing for Severe Vitamin D Deficiency (8 ng/mL)

For an adult with a 25-hydroxyvitamin D level of 8 ng/mL, treat with 50,000 IU of cholecalciferol (vitamin D3) once weekly for 8 weeks, followed by maintenance therapy of 1,500-2,000 IU daily. 1

Correction Phase (8 Weeks)

The Endocrine Society Clinical Practice Guideline provides the most authoritative recommendation for this severe deficiency level:

• 50,000 IU weekly for 8 weeks (total cumulative dose: 400,000 IU) 1
• Alternative equivalent: 6,000 IU daily for 8 weeks 1
• Target: Achieve 25(OH)D level >30 ng/mL 1

This is the standard, evidence-based approach for adults with vitamin D deficiency. The weekly dosing regimen improves adherence compared to daily dosing and has been extensively validated 2, 3.

Why This Specific Regimen

At 8 ng/mL, this patient has severe vitamin D deficiency (defined as <10 ng/mL) 4, 5. The rule of thumb states that 1,000 IU of vitamin D increases serum 25(OH)D by approximately 10 ng/mL, though individual responses vary 2. To raise the level from 8 ng/mL to the target of >30 ng/mL requires roughly 22 ng/mL increase, necessitating aggressive repletion.

Research supports that cumulative doses of 300,000-400,000 IU effectively correct severe deficiency 6, 7, 8. The 50,000 IU weekly × 8 weeks regimen (400,000 IU total) consistently achieves therapeutic levels in clinical trials 1, 7.

Maintenance Phase (After Correction)

Once the 8-week correction phase is complete:

• 1,500-2,000 IU daily for long-term maintenance 1
• Alternative: 50,000 IU every 2 weeks if adherence to daily dosing is problematic 1
• Recheck 25(OH)D level 3-4 months after starting maintenance to confirm adequacy

Important Considerations

Vitamin D3 (cholecalciferol) is strongly preferred over vitamin D2 (ergocalciferol) for intermittent dosing regimens, as D3 maintains serum levels longer 2, 5. While both forms work equivalently with daily dosing, the weekly regimen requires D3 for sustained effect.

Higher doses may be needed if:

• Obesity: Require 2-3 times higher doses (at least 6,000-10,000 IU daily during correction, then 3,000-6,000 IU daily maintenance) 1
• Malabsorption syndromes (celiac disease, Crohn's disease, cystic fibrosis): Same higher dosing as obesity 1
• Medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids, ketoconazole, certain AIDS medications): 2-3 times standard doses 1

Safety Profile

This regimen is safe with minimal toxicity risk. Vitamin D toxicity typically occurs only with:

• Daily doses >50,000 IU sustained over time 3
• 25(OH)D levels >100-150 ng/mL 2, 3

The 50,000 IU weekly regimen for 8 weeks has not been associated with hypercalcemia in clinical trials 1. However, monitor serum calcium if the patient has:

• Granulomatous diseases (sarcoidosis, tuberculosis)
• Lymphoma
• Primary hyperparathyroidism 1

Alternative High-Dose Regimens

While the 50,000 IU weekly × 8 weeks is standard, other evidence-based options exist:

Single or split high-dose loading:

• 300,000 IU as single oral dose for levels 10-20 ng/mL 6
• 600,000 IU total (300,000 IU on consecutive days) for levels <10 ng/mL 6
• These achieve therapeutic levels within 1 week but are less commonly used in standard practice

Daily high-dose:

• 6,000 IU daily for 8 weeks is mathematically equivalent to weekly dosing 1
• May be preferred if weekly dosing compliance is uncertain

Monitoring Strategy

• Recheck 25(OH)D level 2-4 weeks after completing the 8-week correction phase 2
• If level remains <30 ng/mL despite documented adherence, consider malabsorption or need for higher maintenance doses 2, 1
• Once therapeutic level achieved, annual monitoring is reasonable during maintenance therapy

Common Pitfalls to Avoid

1. Don't use calcitriol or other activated vitamin D analogs to treat nutritional vitamin D deficiency—these don't correct 25(OH)D levels 4, 5

2. Don't use vitamin D2 for weekly dosing—it has shorter duration of action than D3 for intermittent regimens 2

3. Don't give single annual mega-doses (e.g., 500,000 IU)—this has been associated with adverse outcomes including increased falls 2

4. Don't forget calcium intake—ensure adequate dietary calcium (1,000-1,200 mg daily from all sources) to optimize bone health 3